Header Logo

Connection

GEORGE CHOLANKERIL to United States

Back to Details
This is a "connection" page, showing publications GEORGE CHOLANKERIL has written about United States.
GEORGE CHOLANKERIL
Connection Strength
1.598
United States
  1. Improved liver transplant outcomes for patients with hilar cholangiocarcinoma following implementation of the MMAT-3 policy. Liver Transpl. 2026 Jun 01; 32(6):823-829.
    View in: PubMed
    Score: 0.077
  2. Inequalities in Developing Cirrhosis Complications Over Time: A Cohort Study. Am J Gastroenterol. 2025 Nov 01; 120(11):2548-2558.
    View in: PubMed
    Score: 0.073
  3. The prevalence and predictors of metabolic dysfunction-associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adults. J Pediatr Gastroenterol Nutr. 2024 07; 79(1):110-118.
    View in: PubMed
    Score: 0.069
  4. Comparable Survival for Hepatitis C-Related Hepatocellular Carcinoma After Liver Transplantation Irrespective of Viremic Status. Clin Gastroenterol Hepatol. 2023 05; 21(5):1362-1364.e1.
    View in: PubMed
    Score: 0.060
  5. Impact of COVID-19 Pandemic on Liver Transplantation and Alcohol-Associated Liver Disease in the USA. Hepatology. 2021 12; 74(6):3316-3329.
    View in: PubMed
    Score: 0.058
  6. Early Impact of COVID-19 on Solid Organ Transplantation in the United States. Transplantation. 2020 11; 104(11):2221-2224.
    View in: PubMed
    Score: 0.054
  7. Regional Trends in Mortality from Alcohol-Induced Causes in the United States, 2000-2017. J Gen Intern Med. 2020 08; 35(8):2495-2498.
    View in: PubMed
    Score: 0.051
  8. Pre-Operative Delta-MELD is an Independent Predictor of Higher Mortality following Liver Transplantation. Sci Rep. 2019 06 05; 9(1):8312.
    View in: PubMed
    Score: 0.049
  9. Temporal Trends Associated With the Rise in Alcoholic Liver Disease-related Liver Transplantation in the United States. Transplantation. 2019 01; 103(1):131-139.
    View in: PubMed
    Score: 0.048
  10. Increasing Trends in Transplantation of HCV-Positive Livers Into Uninfected Recipients. Clin Gastroenterol Hepatol. 2019 07; 17(8):1634-1636.
    View in: PubMed
    Score: 0.047
  11. Impact of Drug Overdose Deaths on Solid Organ Transplantation in the United States. J Gen Intern Med. 2018 09; 33(9):1423-1425.
    View in: PubMed
    Score: 0.047
  12. Increased Waitlist Mortality and Lower Rate for Liver Transplantation in Hispanic Patients With Primary Biliary Cholangitis. Clin Gastroenterol Hepatol. 2018 06; 16(6):965-973.e2.
    View in: PubMed
    Score: 0.045
  13. Alcoholic Liver Disease Replaces Hepatitis C Virus Infection as?the Leading Indication for Liver Transplantation in the United?States. Clin Gastroenterol Hepatol. 2018 08; 16(8):1356-1358.
    View in: PubMed
    Score: 0.044
  14. Rates of liver retransplantation in the United States are declining in the era of direct-acting antiviral agents. J Viral Hepat. 2017 12; 24(12):1194-1195.
    View in: PubMed
    Score: 0.043
  15. Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes. Dig Dis Sci. 2017 10; 62(10):2915-2922.
    View in: PubMed
    Score: 0.043
  16. Disparities in Liver Transplantation Resulting From Variations in Regional Donor Supply and Multiple Listing Practices. Clin Gastroenterol Hepatol. 2017 02; 15(2):313-315.
    View in: PubMed
    Score: 0.041
  17. Trends in Liver Transplantation Multiple Listing Practices Associated With Disparities in Donor Availability: An Endless Pursuit to Implement the Final Rule. Gastroenterology. 2016 09; 151(3):382-386.e2.
    View in: PubMed
    Score: 0.040
  18. Chronic Hepatitis B Is Associated with Higher Inpatient Resource Utilization and Mortality Versus Chronic Hepatitis C. Dig Dis Sci. 2016 09; 61(9):2505-15.
    View in: PubMed
    Score: 0.040
  19. Evolving burden of metabolic dysfunction-associated steatotic liver disease and its complications in a US nationwide healthcare system. Hepatol Commun. 2026 Jan 01; 10(1).
    View in: PubMed
    Score: 0.019
  20. Ambulatory Acute Kidney Injury in Patients With Cirrhosis Is Common and Burdensome. Clin Gastroenterol Hepatol. 2025 Nov; 23(12):2232-2241.e10.
    View in: PubMed
    Score: 0.019
  21. Current Burden of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease Among US Adults, 2017-2023. Aliment Pharmacol Ther. 2025 Mar; 61(5):891-894.
    View in: PubMed
    Score: 0.018
  22. Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023. Clin Mol Hepatol. 2025 Apr; 31(2):382-393.
    View in: PubMed
    Score: 0.018
  23. Is the Transplantation of Elderly and DCD Donors in Low MELD Recipients Justified: An Intent-to-treat Analysis. Transplantation. 2025 05 01; 109(5):823-831.
    View in: PubMed
    Score: 0.018
  24. GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. JAMA Intern Med. 2024 11 01; 184(11):1314-1323.
    View in: PubMed
    Score: 0.018
  25. Burden of mortality from hepatocellular carcinoma and biliary tract cancers by race and ethnicity and sex in US, 2018-2023. Clin Mol Hepatol. 2024 Oct; 30(4):756-770.
    View in: PubMed
    Score: 0.017
  26. Steatotic liver disease-associated all-cause/cause-specific mortality in the United States. Aliment Pharmacol Ther. 2024 07; 60(1):33-42.
    View in: PubMed
    Score: 0.017
  27. Impact of the COVID-19 pandemic on hospitalizations with hepatocellular carcinoma in the United States. Expert Rev Gastroenterol Hepatol. 2024 Jan-Feb; 18(1-3):113-119.
    View in: PubMed
    Score: 0.017
  28. Metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality among adults in the United States. J Hepatol. 2024 02; 80(2):e79-e81.
    View in: PubMed
    Score: 0.017
  29. Depression in nonalcoholic fatty liver disease and all-cause/cause-specific mortality. Eur J Clin Invest. 2024 Jan; 54(1):e14087.
    View in: PubMed
    Score: 0.017
  30. Cost of Care for Patients With Cirrhosis. Am J Gastroenterol. 2024 03 01; 119(3):497-504.
    View in: PubMed
    Score: 0.016
  31. Biliary atresia and liver transplantation in the United States: A contemporary analysis. Liver Int. 2023 10; 43(10):2198-2209.
    View in: PubMed
    Score: 0.016
  32. Trends in aetiology-based hospitalisation for cirrhosis before and during the COVID-19 pandemic in the United States. Aliment Pharmacol Ther. 2023 07; 58(2):218-228.
    View in: PubMed
    Score: 0.016
  33. Transplanting hepatitis B surface antigen-positive livers in the United States: Outcomes and opportunities. Am J Transplant. 2023 08; 23(8):1221-1226.
    View in: PubMed
    Score: 0.016
  34. Disparities in hepatocellular carcinoma survival by Medicaid-status: A national population-based risk analysis. Eur J Surg Oncol. 2023 04; 49(4):794-801.
    View in: PubMed
    Score: 0.016
  35. Chronic liver disease-related mortality in diabetes before and during the COVID-19 in the United States. Dig Liver Dis. 2023 01; 55(1):3-10.
    View in: PubMed
    Score: 0.015
  36. Changing trends in aetiology-based hospitalizations with end-stage liver disease in the United States from 2016 to 2019. Liver Int. 2022 11; 42(11):2390-2395.
    View in: PubMed
    Score: 0.015
  37. Trends in Etiology-based Mortality From Chronic Liver Disease Before and During COVID-19 Pandemic in the United States. Clin Gastroenterol Hepatol. 2022 10; 20(10):2307-2316.e3.
    View in: PubMed
    Score: 0.015
  38. Significant improvements, but consistent disparities in survival for African Americans after liver transplantation. Clin Transplant. 2022 06; 36(6):e14646.
    View in: PubMed
    Score: 0.015
  39. Trends in the Prevalence of Hepatitis C Virus Infection based on the Insurance Status in the United States from 2013 to 2018. Liver Int. 2022 02; 42(2):340-349.
    View in: PubMed
    Score: 0.015
  40. Mortality Trends in Chronic Liver Disease and Cirrhosis in the United States, Before and During COVID-19 Pandemic. Clin Gastroenterol Hepatol. 2021 12; 19(12):2664-2666.e2.
    View in: PubMed
    Score: 0.014
  41. Physical Activity Is Associated With Nonalcoholic Fatty Liver Disease and Significant Fibrosis Measured by FibroScan. Clin Gastroenterol Hepatol. 2022 06; 20(6):e1438-e1455.
    View in: PubMed
    Score: 0.014
  42. Trends in the Mortality of Biliary Tract Cancers Based on Their Anatomical Site in the United States From 2009 to 2018. Am J Gastroenterol. 2021 05 01; 116(5):1053-1062.
    View in: PubMed
    Score: 0.014
  43. Sarcopenia in nonalcoholic fatty liver disease and all-cause and cause-specific mortality in the United States. Liver Int. 2021 08; 41(8):1832-1840.
    View in: PubMed
    Score: 0.014
  44. Trends in mortality in hepatitis C infection and alcoholic liver disease based on drug overdose in the United States. J Viral Hepat. 2021 02; 28(2):436-439.
    View in: PubMed
    Score: 0.014
  45. Nationwide Evolution of Pediatric Endoscopic Retrograde Cholangiopancreatography Indications, Utilization, and Readmissions over?Time. J Pediatr. 2021 05; 232:159-165.e1.
    View in: PubMed
    Score: 0.014
  46. Prevalence of Fatty Liver Disease and Fibrosis Detected by Transient Elastography in Adults in the United States, 2017-2018. Clin Gastroenterol Hepatol. 2021 07; 19(7):1499-1501.e2.
    View in: PubMed
    Score: 0.013
  47. Gender and Racial Differences in Hospitalizations for Primary Biliary Cholangitis in the USA. Dig Dis Sci. 2021 05; 66(5):1461-1476.
    View in: PubMed
    Score: 0.013
  48. Decline in Annual Mortality of Hepatitis C Virus-Related Hepatocellular Carcinoma in the United States, From 2009 to 2018. Gastroenterology. 2020 10; 159(4):1558-1560.e2.
    View in: PubMed
    Score: 0.013
  49. Suboptimal Use of Inpatient Palliative Care Consultation May Lead to Higher Readmissions and Costs in End-Stage Liver Disease. J Palliat Med. 2020 01; 23(1):97-106.
    View in: PubMed
    Score: 0.012
  50. Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study. Dig Dis Sci. 2020 04; 65(4):990-1002.
    View in: PubMed
    Score: 0.012
  51. Depression is associated with non-alcoholic fatty liver disease among adults in the United States. Aliment Pharmacol Ther. 2019 09; 50(5):590-598.
    View in: PubMed
    Score: 0.012
  52. Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017. Gastroenterology. 2019 10; 157(4):1055-1066.e11.
    View in: PubMed
    Score: 0.012
  53. Increasing Mortality Among Patients With Diabetes and Chronic Liver Disease From 2007 to 2017. Clin Gastroenterol Hepatol. 2020 04; 18(4):992-994.
    View in: PubMed
    Score: 0.012
  54. Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014. Liver Int. 2019 09; 39(9):1661-1671.
    View in: PubMed
    Score: 0.012
  55. Hepatocellular carcinoma is leading in cancer-related disease burden among hospitalized baby boomers. Ann Hepatol. 2019 Sep - Oct; 18(5):679-684.
    View in: PubMed
    Score: 0.012
  56. Trends in overall, cardiovascular and cancer-related mortality among individuals with diabetes reported on death certificates in the United States between 2007 and 2017. Diabetologia. 2019 07; 62(7):1185-1194.
    View in: PubMed
    Score: 0.012
  57. Elevated urinary bisphenol A levels are associated with non-alcoholic fatty liver disease among adults in the United States. Liver Int. 2019 07; 39(7):1335-1342.
    View in: PubMed
    Score: 0.012
  58. Association of Pretransplant Renal Function With Liver Graft and Patient Survival After Liver Transplantation in Patients With Nonalcoholic Steatohepatitis. Liver Transpl. 2019 03; 25(3):399-410.
    View in: PubMed
    Score: 0.012
  59. Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States. Hepatology. 2019 03; 69(3):1064-1074.
    View in: PubMed
    Score: 0.012
  60. Race/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005-2016. Hepatol Int. 2019 Mar; 13(2):205-213.
    View in: PubMed
    Score: 0.012
  61. Low-Normal Thyroid Function Is Associated With Advanced Fibrosis Among Adults in the United States. Clin Gastroenterol Hepatol. 2019 10; 17(11):2379-2381.
    View in: PubMed
    Score: 0.012
  62. Disparate Trends in Mortality of Etiology-Specific Chronic Liver Diseases Among Hispanic Subpopulations. Clin Gastroenterol Hepatol. 2019 07; 17(8):1607-1615.e2.
    View in: PubMed
    Score: 0.012
  63. Disparities in mortality for chronic liver disease among Asian subpopulations in the United States from 2007 to 2016. J Viral Hepat. 2018 12; 25(12):1608-1616.
    View in: PubMed
    Score: 0.012
  64. Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016. Gastroenterology. 2018 10; 155(4):1154-1163.e3.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.